Endometrial cancer and HRT

Reviews in Gynaecological Practice

Volumn 5, Issue 1, 2005, Pages 51-56

  Sturdee, David W ^a  

^a SOLIHULL HOSPITAL   (United Kingdom)

Author keywords

Endometrial cancer; HRT; Intrauterine progestogen; Progestogen

Indexed keywords

CONJUGATED ESTROGEN; ESTRIOL; ESTROGEN; GESTAGEN; LEVONORGESTREL; MEDROXYPROGESTERONE ACETATE; PLACEBO; RALOXIFENE;

ARTICLE; CANCER RISK; CANCER STAGING; CLINICAL TRIAL; ENDOMETRIAL DISEASE; ENDOMETRIOSIS; ENDOMETRIUM ATROPHY; ENDOMETRIUM CANCER; ENDOMETRIUM CARCINOMA; ENDOMETRIUM HYPERPLASIA; FEMALE; HORMONE SUBSTITUTION; HUMAN; LONG TERM CARE; MEDICAL INSTRUMENTATION; MENOPAUSAL SYNDROME; MENORRHAGIA; POSTMENOPAUSE; PROTECTION; RISK ASSESSMENT; RISK REDUCTION; SHORT COURSE THERAPY; UTERUS BLEEDING;

EID: 18144416978     PISSN: 14717697     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rigp.2005.01.001     Document Type: Article

References (40)

1. N.S. Weiss D.R. Szekely D.R. English A.I. Schweid Endometrial cancer in relation to patterns of menopausal oestrogen use. JAMA 242 1979 261-264
2. M.C. Pike R.K. Peters W. Cozen et al. Estrogen-progestin replacement therapy and endometrial cancer. J Nat Cancer Inst 89 1997 1110-1116
3. B.E. Henderson J.T. Casagrande M.C. Pike et al. The epidemiology of endometrial cancer in young women. Br J Cancer 47 1983 749-756
4. R. Horwitz A.R. Feinstein Alternative analytic methods for case control studies of oestrogens and endometrial cancer. N Eng J Med 299 1978 1089-1094
5. C.M.F. Antunes P.D. Stolley M.B. Rosenstein et al. Endometrial cancer and oestrogen use. Report of a large case-control study. N Eng J Med 300 1979 9-13
6. Paganini-Hill R.K. Ross B.E. Henderson Endometrial cancer and patterns of use of Oestrogen Replacement Therapy: A Cohort study. Br J Cancer 59 1989 445-447
7. P.K. Green N.S. Weiss B. McKnight L.F. Voigt S.A. Beresford Risk of endometrial cancer following cessation of menopausal hormone use. Cancer Causes Control 7 1996 575-580
8. R.F. Casper Regulation of estrogen/progestogen receptors in the endometrium. Int J Fertil Menop Stud 41 1996 16-21
9. L.C. Horn U. Schnurrbusch K. Bilek B. Hentschel J. Einenkel Risk of progression in complex and atypical endometrial hyperplasia: clinicopathologic analysis in cases with and without progestogen treatment. Int J Gynecol Cancer 14 2004 348-353
10. D.F. Archer K. McIntyre-Seltman W.W. Wilborn Jr. et al. Endometrial morphology in asymptomatic postmenopausal women. Am J Obstet Gynecol 165 1991 317-322
11. M.O. Korhonen J.P. Symons B.M. Hyde J.P. Rowan W.H. Wilburn Histologic classification and pathologic findings for endometrial biopsy specimens obtained from 2964 perimenopausal and postmenopausal women undergoing treatment with continuous hormones as replacement therapy (CHART 2 study). Am J Obstet Gynecol 83 1997 686-692
12. Writing Group for the PEPI Trial Effects of hormone replacement therapy on endometrial histology in postmenopausal women. The post-menopausal Estrogen/Progestin Interventions (PEPI) Trial. JAMA 275 1996 370-375
13. A. Lethaby J. Suckling D. Barlow C. Farquhar R. Jepson H. Roberts Hormone replacement therapy in postmenopausal women: Endometrial hyperplasia and irregular bleeding. Cochrane Database Syst Rev 3 2004 CD000402
14. M. Notelowitz R.E. Varner R.W. Rebar Minimal endometrial proliferation over a two year period in taking 0.3 mg of unopposed esterified estrogens. Menopause 4 1997 80-88
15. K.L. Cushing N.S. Weiss L.F. Voigt B. McKnight S.A. Beresford Risk of endometrial cancer in relation to use of low dose unopposed estrogens. Obstet Gynecol 91 1998 35-39
16. M.E.L. Paterson T.E. Wade-Evans D.W. Sturdee M.H. Thom J.W.W. Studd Endometrial disease after treatment with oestrogens and progestogens in the climacteric. Br Med J 280 1980 822-824
17. M.I. Whitehead J. McQueen R.J. Beard J. Minardi S. Campbell The effects of cyclical oestrogen therapy and sequential oestrogen therapy on the endometrium of post-menopausal women. Acta Obstet Gynecol Scand (Suppl) 65 1977 91-101
18. D.W. Sturdee T.E. Wade-Evans M.E.L. Paterson M. Thom J.W.W. Studd Relations between bleeding pattern, endometrial histology and oestrogen treatment in post-menopausal women. Br Med J 1 1978 1575-1577
19. D.W. Sturdee L.G. Ulrich D.H. Barlow et al. The endometrial response to sequential and continuous combined oestrogen-progestogen replacement therapy. Br J Obstet Gynaecol 107 2000 1392-1400
20. I. Persson H.O. Ajami L. Bergkvist A. Lindgrin B. Pettersson R. Hoover et al. Risk of endometrial cancer after treatment with oestrogens alone or in conjunction with progestogens: Results of a prospective study. Br Med J 298 1989 147-151
21. J.A.A. Beresford N.S. Weiss L.F. Voigt B. Mcknight Risk of endometrial cancer in relation to use of oestrogen combined with cyclic progestogen therapy in post-menopausal women. Lancet 349 1997 458-461
22. B. Ettinger J. Selby J.T. Citron A. Vangessel Cyclic HRT using quarterly progestin. Obstet Gynecol 83 1994 693-700
23. K. Bjarnson A. Cerin R. Lindgren T. Weber The Scandinavian Long Cycle Study Group Adverse endometrial effects during long cycle hormone replacement therapy. Maturutas 32 1999 161-170
24. E. Pukkala A. Tulenheimo-Silfvast A. Leminem Incidence of cancer among women using long versus monthly cycle HRT, Finland 1994-1997 Cancer Causes Control 12 2001 111-115
25. The Menopause Study Group J.D. Woodruff J.H. Pickar Incidence of endometrial hyperplasia in postmenopausal women taking conjugated estrogens (Premarin) with medroxyprogesterone acetate or conjugated estrogens alone Am J Obstet Gynecol 170 1994 1213-1223
26. A.T. Leather M. Savvas J.W.W. Studd Endometrial histology and bleeding patterns after 8 years of continuous combined oestrogen and progestogen therapy in post-menopausal women. Obstet Gynecol 78 1991 1008-1010
27. J.T. Comerci A.L. Fields C.D. Runowicz G.L. Golaberg Continuous low dose combined hormone replacement therapy and the risk of endometrial cancer Gynecol Oncol 64 1997 425-430
28. D.A. Hill N.S. Weiss S.A. Beresford et al. Continuous combined hormone replacement therapy and risk of endometrial cancer. Am J Obstet Gynecol 183 2000 1456-1461
29. G.L. Anderson H.L. Judd A.M. Kaunitz et al. Effects of estrogen plus progestin on gynaecological cancers and associated diagnostic procedures: The Women's Health Initiative randomised trial. JAMA 291 2004 1739-1748
30. M. Wells D.W. Sturdee D.H. Barlow et al. Effect on endometrium of long term, treatment with continuous combined oestrogen-progestogen replacement therapy: Follow up study. Br Med J 325 2002 239-242
31. E. Wiederpass Risk of endometrial cancer following estrogen replacement with and without progestins. J Nat Cancer Inst 91 1999 1131-1137
32. W. Völker H.J.T. Coelingh Bennink F.A. Helmond Effects of tibolone on the endometrium. Climacteric 4 2001 203-208
33. D. Bruce J. Robinson J. Rymer Long-term effects of tibolone on the endometrium as assessed by bleeding episodes, transvaginal scan and endometrial biopsy. Climacteric 7 2004 261-266
34. P.D. Delmas N.H. Bjarnason J. Mitlak et al. Effects of raloxifene on bone mineral density, serum cholesterol concentrations and uterine endometrium in postmenopausal women. N Eng J Med 337 1997 1641-1647
35. P. Fugene W.H. Scheele A. Shah T.R. Strack M.D. Glant E. Jolly Uterine effects of raloxifene in comparison with continuous-combined HRT in post-menopausal women. Am J Obstet Gynecol 182 2000 568-574
36. Million Women Study Collaborators Breast cancer and hormone replacement therapy in the Million Women Study Lancet 362 2003 419-427
37. F.E. Riphagen Intrauterine application of progestins in hormone replacement therapy. Climacteric 3 2000 199-211
38. T. Raudaskoski J. Tapanainen E. Tomás et al. Intrauterine 10 and 20 μg levonorgestrel systems in postmenopausal women receiving oral oestrogen replacement therapy: Clinical, endometrial and metabolic response. Brit J Obstet Gynaecol 109 2002 136-144
39. W.T. Creasman D. Henderson W. Hinshaw Dl. Clarke-Pearson Estrogen replacement therapy in the patient treated for endometrial cancer. Obstet Gynecol 67 1986 326-330
40. K.A. Suriano M. McHale C.E. McLaren et al. Estrogen replacement therapy in endometrial cancer patients: A matched control study. Obstet Gynecol 97 2001 555-560